Scancell Hldgs Plc

Research Scancell Hldgs Plc (SCLP) on Bullrun: market cap GBX 21.79B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSCLP
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 21.79B
• Financial periodFY2025

Valuation Snapshot

latest market cap is GBX 21.79B.

About Scancell Hldgs Plc

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer.

Frequently asked questions

What is Scancell Hldgs Plc's market cap?

Scancell Hldgs Plc's market capitalization is GBX 21.79B.

What does Scancell Hldgs Plc do?

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma;